🇺🇸 FDA
Patent

US 7148201

Use of human plasma hyaluronidase in cancer treatment

granted A61KA61K38/00A61P

Quick answer

US patent 7148201 (Use of human plasma hyaluronidase in cancer treatment) held by The Regents of the University of California expires Mon Dec 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K38/00, A61P, A61P35/00